AMRX Competitors & Alternatives
Compare Amneal Pharmaceuticals, Inc. Class A Common Stock with similar stocks in the same industry
Drug Manufacturers - Specialty & Generic
AMRX
Main Stock$17.01
Tradestie Score
52
Market Cap
$3.26B
P/E Ratio
35.9
Revenue Growth
0.1%
Analyst Upside
+23.5%
Top Competitors
45 stocks in Drug Manufacturers - Specialty & Generic| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
RGC
Regencell Bioscience Holdings Limited Ordinary Shares
|
$5.64
|
$7.83B | - | 45 | Compare |
|
ALKS
Alkermes Inc. plc
|
$45.97
|
$5.06B | 118.2 | 59 | Compare |
|
PTGX
Protagonist Therapeutics, Inc
|
$148.18
|
$3.98B | 140.9 | 59 | Compare |
|
LNTH
Lantheus Holdings, Inc
|
$100.25
|
$3.51B | 24.0 | 46 | Compare |
|
PBH
Prestige Consumer Healthcare Inc.
|
$46.95
|
$3.12B | 13.6 | 36 | Compare |
|
PRGO
PERRIGO COMPANY PLC
|
$13.66
|
$3.10B | - | 30 | Compare |
|
INDV
Indivior PLC Ordinary Shares
|
$34.49
|
$2.93B | 12.5 | 69 | Compare |
|
KNSA
Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares
|
$76.27
|
$2.86B | 79.7 | 54 | Compare |
|
HCM
HUTCHMED (China) Limited American Depositary Shares
|
$12.82
|
$2.74B | 131.2 | 35 | Compare |
|
SUPN
Supernus Pharmaceuticals, Inc.
|
$41.64
|
$2.69B | - | 42 | Compare |
More AMRX Analysis
Data updated: Sep 12, 2026 | Industry: Drug Manufacturers - Specialty & Generic (SIC 2834)
45 stocks in this industry